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Abstract
Aesthetic is nowadays becoming as one of the important things for people to increase self-confidence. 
Flawless skin could be one of the desired looks especially for females which is a valuable cosmetics 
market. Skin browning is often associated with dermatological problems which may lead to 
hyperpigmentation due to the increase of the melanin biosynthesis. Skin browning could be caused by 
the overproduction of melanin which is accelerated by the presence of human tyrosinase. Therefore, 
the inhibition of this kind of enzyme is associated with skin lightening. In this present study, we 
perform in silico virtual screening against human tyrosinase by utilizing a natural product database 
from Indonesia Herbal Database (http://herbaldb.farmasi.ui.ac.id/v3/) to select 20 hit compounds. The 
simulation was carried using AutoDock Vina via molecular docking. The result shows that from 200 
compounds of the database, those hits have a free energy of binding range from -12.1 to -9.2 kcal/mol 
predicting the affinity of the corresponding compounds towards human tyrosinase associating with its 
potential as a skin whitening agent. The hits correspond to their presence in Indonesian local plant that 
could be potential as resources for skin whitening.
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Eksplorasi Tanaman Indonesia Sebagai Pencerah Kulit Melawan 
Tirosinase: Penapisan Maya 
Abstrak
Estetika saat ini menjadi salah satu hal penting bagi orang untuk meningkatkan kepercayaan diri. 
Kulit yang putih dan sehat bisa menjadi salah satu penampilan yang diinginkan terutama untuk wanita 
yang merupakan pasar kosmetik yang berharga. Penggelapan kulit dapat disebabkan oleh peningkatan 
melanin yang dipercepat oleh aktivitas tirosinase manusia. Oleh karena itu, penghambatan enzim ini 
dikaitkan dengan pencerahan kulit. Dalam penelitian ini, kami melakukan penapisan maya terhadap 
tirosinase manusia dengan memanfaatkan basis data produk alami dari Database Herbal Indonesia 
untuk memilih 20 senyawa hit. Simulasi dilakukan dengan menggunakan AutoDock Vina melalui 
penambatan molekuler. Hasil menunjukkan bahwa dari 200 senyawa dari database, diperoleh 20 
senyawa hit memiliki energi bebas ikatan berkisar dari -12,1 hingga -9,2 kkal / mol menunjukkan 
afinitas yang baik terhadap tirosinase manusia yang berkaitan dengan potensinya sebagai agen pemutih 
kulit. Hit tersebut kemudian dihubungkan dengan keberadaan mereka di tanaman lokal Indonesia yang 
dapat berpotensi sebagai sumber daya untuk pemutihan kulit.
Kata Kunci: Tanaman Indonesia, penambatan molekuler, tirosinase, penapisan maya.
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1. Introduction
Healthy and beautiful skin is pursued 
especially in females which has been a 
potential market for cosmetic industries.1 
Nowadays, people start to beautify themselves 
no matter how expensive they have to expend 
their money for cosmetics.2 Skin whitening 
agent has been attracting women for a long 
time to manipulate their dark skin to be 
more flawless.3 Unfortunately, further study 
shows that some whitening agent is no longer 
acceptable to be applied due to their toxicity 
such as skin cancer.4 As reported, mercury 
and hydroquinone have been banned in the 
market as they showed carcinogenesis and 
irritating properties, respectively.5
Skin browning is often associated with 
the dermatological problem which may lead 
to hyperpigmentation due to the increase of 
the melanin biosynthesis.6 At the molecular 
stage, this condition is catalyzed by an 
enzyme called as tyrosinase which facilitates 
the hydroxylation of L-tyrosine (tyrosine 
monophenol) to 3,4-dihydroxy-phenylalanine 
(L-DOPA) as well as the oxidation of L-DOPA 
to give dopaquinone.7 There have been two 
current tyrosinase inhibitors available in the 
market i.e., kojic acid and hydroquinone8, but 
as previously mentioned, hydroquinone has 
been discouraged to be used as depigmentation 
due to its skin irritating properties.9 Other 
compounds such as benzylidene aniline10, 
biphenyl analogue11, dialkylphosphoryl 
hydrazone12, metimazole13, benzaldehyde 
thiosemicarbazone14, benzylidene 
thiobarbiturate15, N-benzylbenzamide16, 
hydroxynaphthyl benzenetriol17, and many 
more18-20 have been reported as synthetic 
tyrosinase inhibitors.
Instead of synthetic compounds which 
have been used in depigmentation, natural 
product is also an abundant resource to serve 
the same activity by inhibiting tyrosinase21. 
As reported, genus Piper, Strypnodendron 
barbatimao, Portulaca pilosa, Cariniana 
braziliensis, etc.22-24 demonstrate good 
activities to inhibit tyrosinase. The interesting 
compound isolated from L. molleoides .i.e., 
(Z,Z)-5-(trideca-4,7-dienyl)-resorcinol is 37 
times more active than kojic acid.25
Indonesia is included in the top mega 
biodiversity of the world26 that must be rich 
in the natural product compounds serving 
as tyrosinase inhibitor resources. In this 
present study, we perform virtual screening to 
have a short list of 20 compounds from 200 
natural product compounds in the database 
which are in silico active against human 
tyrosinase via molecular docking simulation. 
These compounds correspond to the local 
Indonesian plant which could be suggested as 
the resource of tyrosinase inhibitors.
2. Methods
2.1. Equipment
HP laptop with Intel i3-500 5U Quad 
Core @2.0GHz with Windows 10, 4GB RAM 
and 500GB HDD.
2.2. Materials
The soft files used in this work are 
PDB 5M8S from protein data bank (www.
rcsb.org), Indonesian Herbal Database 
(http://herbaldb.farmasi.ui.ac.id/v3/), and 
compounds collected from references.27-29
The software used for constructing 
and energy minimization of 2D chemical 
structure is Marvin Sketch (https://chemaxon.
com), whereas Discovery Studio 4.1 (www.
accelrys.com) is used to convert them into 
3D structure. The virtual screening uses the 
molecular docking protocol in AutoDock 
Vina (www.scripps.edu) and the output is 




The crystal structure was downloaded 
from protein data bank with PDB ID 
5M8S (www.rcsb.org) consisting of human 
tyrosinase with phenylthiourea used as the 
control ligand located at the pocket site. The 
tyrosinase is presented in tetramer, therefore, 
only a monomer used for molecular modeling. 
The co-crystal ligand (phenylthiourea = URS) 
is separated from human tyrosinase using 
Discovery Studio 4.1 and total hydrogens 
were added, and then saved as pdb file. 
Human tyrosinase was prepared using the 
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same program used to give total hydrogens 
and saved as pdb file. The grid box was 
automatically defined by PyRx program 
(exhaustiveness = 32; size 20.10, 20, 20 and 
center x = 121.762, y= 139.470, z= 216.382) 
and the docking was run using AutoDock 
Vina30 embedded in PyRx program. The 
docking parameter is defined as valid if giving 
the RMSD value less than 2Å.31
2.3.2. External Docking
There are several compounds published 
as inhibitors for tyrosinase27-29 that could be 
used for external validation before the docking 
parameters used for virtual screening. The 
compounds having the activity within 0.15 
– 38.0 µM are sketched and energetically 
optimized (MM+ force field) using Marvin 
Sketch program. The compounds were then 
docked to the human tyrosinase using the 
same parameter with control docking. The 
observed free energy of binding was then 
collected and ranked from the lowest to 
highest binding affinity and calculated its 
coefficient correlation against experimental 
IC50. The extrapolation of binding affinity vs 
log IC50 was conducted using Microsoft Excel 
2016.
2.3.3. Virtual Screening
The natural product compounds (200) 
were downloaded from Indonesia Herbal 
Database (http://herbaldb.farmasi.ui.ac.id/
v3/), then prepared to pdb file using Discovery 
Studio 4.1. The virtual screening was then 
performed using the same protocol with 
control docking as defined. The output was 
then collected in csv file and the compounds 
were ranked according to the free energy of 
binding. There are 20 compounds with the 
lowest energy binding shortlisted as the in 
silico hits compounds.
3. Results
The control docking pose is found at the 
same binding site with the initial pose with 
RMSD lower bound and upper bound are 
1.58 Å and 2.12 Å as shown in Figure 1 The 
linear regression is generated to see whether 
the docking parameter able to predict the nine 
ligand binding affinities which correlates 
with its log IC50. Interestingly, the correlation 
coefficient (R2) is equal to 0.7089 as shown in 
Figure 2. The virtual screening of 200 ligands 
collected from Indonesia Herbal Database is 
then conducted to shortlist 20 hits based on 
the rank of binding affinities (kcal/mol). The 
binding affinities as shown in Table 1 range 
from -12.1 to -9.2 kcal/mol
Eighteen out of 20 ligands are docked at 
the same binding site with URS as well as nine 
external ligands. Two ligands which bound to 
Fig 1. The superposition of initial pose (yellow carbon) and control docking pose (green carbon) of 
URS into human tyrosinase binding site.
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extra binding sites are digoxin and digitoxin. 
These could be a potential allosteric site 
which able to change active site conformation 
through signal transduction from ligand-
allosteric site binding. However, we do not 
study this assumption but suggest to carry out 
this for further study. Sequioaflavone binds the 
active site of human tyrosinase with binding 
affinity = -10.4 kcal/mol by interacting with 
TYR69 and ARG114 as shown in Figure 4.
4-prenylresveratrol interacts with 
PRO242 at human tyrosinase’s main binding 
Fig 2. The graph extrapolating free energy of binding/ binding affinities (kcal/mol) vs log IC50
Ligands Binding Energy (kcal/mol) Plants (in Latine )
Digitoxin -12.1 Cordylin fructicose
Gitoxin -12.1 Cordylin fructicose
Digoxin -11 Cordylin fructicose
Beta-citraurin -10.7 Capsicum annuum
Sequioaflavone -10.4 Elateriospermum tapos
Poncirin -10.3 Citrus aurantifolia
Glyceollin I -10.1 Glycine Soja
Ophiopogonin C -9.9 Parkia javanica
Chlorogenic acid -9.7 Mimosa pudica
Apigetrin -9.7 Sambucus nigra
Asiaticoside F -9.5 Centella asiatica
4-prenylresveratrol -9.5 Arachis hypogaea
Sappanone B -9.4 Caesania sappan
Hydroxyanthraquinone -9.4 Rhamnus purshiana
Fargesin -9.3 Magnolia coco
Betanine -9.3 Beta vulgaris
2’-O-methylvestitol -9.3 Gliricidia maculata
Liquiritigenin -9.3 Jasminum sambac
Euxanthone -9.2 Caesania sappan
Apoviolaxanthinal -9.2 Citrus sinensis
Table 1. The free energy binding of 20 hit compounds alongside with their binding energy values as 
well as their plants where the ligand is deposited in.
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site with binding affinity = -9.5 kcal/mol as 
shown in Figure 5.
4. Discussions
The result of control docking showed 
the RMSD lower bound and upper bound are 
1.58 Å and 2.12 Å, respectively, indicating 
the docking parameterization is acceptable 
for designing new ligands. The deviation 
of docking and the initial pose is due to 
the tautomeric state being caused by the 
protonation of nitrogen atom. This is still our 
preliminary prediction but it still requires 
further molecular experiments to confirm 
these phenomena.
External docking result reflects 
considerably good docking parameters 
in predicting the activity of these ligands 
and the docking parameters can be used to 
predict the binding affinities of 200 ligands 
from Indonesian Herbal Database via virtual 
screening. 20 hit compounds have been 
discovered from virtual screening and having 
binding affinities range from -12.1 to -9.2 kcal/
mol associating with the capabilities of the hits 
to strongly interact with human tyrosinase. To 
Fig 3. The superposition of 20 hits docking pose into human tyrosinase binding site. Digoxin is bound 
to the extra binding site 1, whereas digitoxin is bound to the extra binding site 2.
Fig 4.The docking pose of sequioaflavone into human tyrosinase binding site. 
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be a drug candidate, ligand should meet the 
requirement by the Lipinski rule of five. This 
rule defines a drug should have a molecular 
weight (MW) not greater than 500, partition 
coefficient (logP) not greater than 5, number 
of hydrogen bond donor (HBD) not greater 
than 5 and the number of hydrogen bond 
acceptor (HBA) up to 10. According to this 
rule, we can narrow down to select only two 
ligands that roughly meet the requirement of 
Lipinski rule of five. They are sequioaflavone 
(MW = 552.91; logP = 5.4; HBD = 5 and 
HBA = 10.) and 4-prenylresveratrol (MW = 
296.36; logP = 5.1; HBD = 3 and HBA = 4) 
which are contained in Elateriospermum tapos 
and Arachis hypogaea, A relevant prove that 
strengthen 4-prenylresveratrol activity is the 
activity of resveratrol, a chemical substance 
contained in grapes and has been used as 
anti-aging due to its capability to inhibit 
sirtuin activity. It is believed that sirtuins play 
a key role during cell response to a variety 
of stresses, such as oxidative or genotoxic 
stress and are crucial for cell metabolism.32 It 
is, therefore, can be said that resveratrol has 
a double activity, could be on one hand acts 
on sirtuin and on the other hand, inhibit the 
human tyrosinase which gives a synergistic 
activity.
5. Conclusion
There have been conducted virtual 
screening by using molecular docking to select 
20 hits from 200 natural product compounds 
in the database. The 20 top hits were then 
further selected its properties should meet 
the requirement as defined by the Lipinski 
rule of five. As evaluated, two ligands i.e 
sequioaflavone and 4-prenylresveratrol have 
been further selected as a potential inhibitor 
for human tyrosinase associating with skin 
lightening activity. The plants belong to 
sequioaflavone and 4-prenylresveratrol are 
respectively Elateriospermum tapos and 
Arachis hypogaea.
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